pindolol has been researched along with mdl 100907 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Andrade, R; Béïque, JC; Chapin-Penick, EM; Mladenovic, L | 1 |
| Baranowska, M; Kozłowska, H; Kozłowski, M; Malinowska, B; Schlicker, E | 1 |
| Kuypers, KP; Ramaekers, JG; Wingen, M | 2 |
2 trial(s) available for pindolol and mdl 100907
| Article | Year |
|---|---|
Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Topics: Administration, Oral; Adult; Affect; Brain; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Mental Recall; Pindolol; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Space Perception; Verbal Learning | 2007 |
The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Topics: Administration, Oral; Adult; Attention; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Pindolol; Psychomotor Performance; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sleep | 2007 |
3 other study(ies) available for pindolol and mdl 100907
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamines; Animals; Bicuculline; Fluorobenzenes; GABA-A Receptor Antagonists; Glutamic Acid; Indoles; Lidocaine; Male; Patch-Clamp Techniques; Phenols; Pindolol; Piperidines; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sodium Channel Blockers; Sulfonamides; Synapses; Tetrodotoxin; Time Factors | 2004 |
Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents | 2006 |